Durvalumab and Anlotinib Boost Small-Cell Lung Cancer Treatment
In a groundbreaking advancement poised to reshape the therapeutic landscape for extensive-stage small-cell lung cancer (ES-SCLC), a multicenter, randomized phase ...
In a groundbreaking advancement poised to reshape the therapeutic landscape for extensive-stage small-cell lung cancer (ES-SCLC), a multicenter, randomized phase ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine